不良研究所

gerald bronfman department of oncology divisions and programs

Divisions & Programs

不良研究所 GBDO Faculty Members

The Department's faculty conduct their cancer-related activities as a member of one or more of the Department's Divisions and Programs. To view the individual profiles of each faculty member and find out which Division(s)/Program(s) they belong to, visit the听Faculty Members听page by clicking below.


Collectively, the Department鈥檚 members have a broad range of experience and expertise in oncology clinical care and cancer research. On the clinical side, we have medical, surgical and radiation oncologists, hematologic-oncologists, gynecologic-oncologists, radiation physicists, psychologists with expertise in psychosocial oncology, physicians who focus on palliative and supportive care and cancer geneticists. On the research side we have basic scientists, population health researchers, medical physicists, psychosocial oncology and palliative care researchers and clinicians conducting clinical research. Oncology clinical care typically involves an interdisciplinary team of health care professionals while cancer researchers in the Department have forged intradisciplinary and interdisciplinary research collaborations with other Department members.

Areas of Research

  • Basic research focusing on understanding at the molecular, cellular, and tissue levels the development and growth of tumours.
  • Translational research for the development and testing of novel therapeutics and understanding drug resistance.
  • Phase I, II and III clinical research studies testing the efficacy of new cancer treatment therapies.
  • Radiation physics studies to improve the delivery of radiotherapy.
  • Genetic studies of inherited susceptibility to cancer.
  • Epidemiologic studies of cancer etiology, prevention, and prognosis.
  • Research aimed at improving the emotional well-being and quality of life of individuals with cancer and their families, and managing pain and other symptoms of the disease.
  • Research on processes for continued improvements in the quality and cost-effectiveness of cancer care.

Back to top